ContraFect Corporation (CFRXQ)
USD 0.0
(-50.0%)
USD 0.0
(-50.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -65.15 Million USD | -221.24% |
| 2021 | -20.28 Million USD | 27.96% |
| 2020 | -28.15 Million USD | -120.06% |
| 2019 | -12.79 Million USD | 66.05% |
| 2018 | -37.68 Million USD | -142.85% |
| 2017 | -15.51 Million USD | 45.63% |
| 2016 | -28.53 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q2 | -7.56 Million USD | -452.01% |
| 2023 Q3 | -5.35 Million USD | 29.19% |
| 2023 Q1 | -1.37 Million USD | 86.07% |
| 2022 Q1 | -20.15 Million USD | -364.55% |
| 2022 Q3 | -17.06 Million USD | 5.65% |
| 2022 Q4 | -9.83 Million USD | 42.35% |
| 2022 Q2 | -18.08 Million USD | 10.26% |
| 2022 FY | -65.15 Million USD | -221.24% |
| 2021 Q3 | -5.29 Million USD | 0.0% |
| 2021 FY | -20.28 Million USD | 27.96% |
| 2021 Q4 | -4.33 Million USD | 18.01% |
| 2020 FY | -28.15 Million USD | -120.06% |
| 2019 FY | -12.79 Million USD | 66.05% |
| 2018 FY | -37.68 Million USD | -142.85% |
| 2017 FY | -15.51 Million USD | 45.63% |
| 2016 FY | -28.53 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -4778.799% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -833.045% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 222.979% |
| Nascent Biotech, Inc. | -2.08 Million USD | -3020.83% |
| Rebus Holdings, Inc. | -1.02 Million USD | -6287.549% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 200.031% |
| Qrons Inc. | -789.34 Thousand USD | -8154.038% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -10202.384% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | -4.08% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -15581.418% |
| Skye Bioscience, Inc. | -37.64 Million USD | -73.073% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 13.086% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -890.753% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -23730.477% |
| SQZ Biotechnologies Company | -79.46 Million USD | 18.009% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -2152.563% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -3478.797% |
| Mesoblast Limited | -87.95 Million USD | 25.925% |
| Marizyme, Inc. | -65.34 Million USD | 0.297% |
| Genus plc | 7.9 Million USD | 924.722% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -498.187% |
| Pharming Group N.V. | -10.54 Million USD | -517.681% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -2902.7% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -1656.035% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -636.692% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -1233.446% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -3671.618% |
| IMV Inc. | -36.48 Million USD | -78.571% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -708.382% |
| MultiCell Technologies, Inc. | -380.07 USD | -17142268.511% |
| ONE Bio Corp. | 8.67 Million USD | 850.904% |
| Accustem Sciences Inc. | -3.74 Million USD | -1639.074% |
| RVL Pharmaceuticals plc | -51.69 Million USD | -26.041% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -5041.761% |
| Q BioMed Inc. | -2.05 Million USD | -3074.954% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -1645.325% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -2636.521% |
| Biomind Labs Inc. | -1.21 Million USD | -5265.394% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | -9.088% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -2000.512% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -724.399% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -3242.467% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -434949.412% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -310.505% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -1019.996% |
| GB Sciences, Inc. | -1.36 Million USD | -4684.762% |
| Alpha Cognition Inc. | -13.77 Million USD | -373.064% |
| HST Global, Inc. | -146.21 Thousand USD | -44461.248% |
| CSL Limited | 2.64 Billion USD | 102.466% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -3612.906% |
| Halberd Corporation | -79.67 Thousand USD | -81672.428% |
| Enzolytics Inc. | -2.17 Million USD | -2893.019% |
| Agentix Corp. | -1.37 Million USD | -4641.121% |
| Resverlogix Corp. | -3.61 Million USD | -1704.792% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -1954.369% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 77.918% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 66582.653% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 1040.893% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -1539.897% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -2053.01% |
| AVAX Technologies, Inc. | -6.41 Million USD | -915.849% |
| Zenith Capital Corp. | -10.59 Million USD | -514.883% |
| Genscript Biotech Corporation | -95.47 Million USD | 31.761% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -280224.413% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -1471.491% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -107696.728% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -3149.34% |
| Kadimastem Ltd | -3.3 Million USD | -1869.917% |
| Helix BioMedix, Inc. | -1.05 Million USD | -6069.459% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -1606.023% |
| BioStem Technologies, Inc. | -8.48 Million USD | -668.043% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -14661.571% |
| LadRx Corporation | 400.44 Thousand USD | 16370.231% |
| Cell Source, Inc. | -5.32 Million USD | -1124.402% |
| Regen BioPharma, Inc. | 1.02 Million USD | 6465.656% |
| Regen BioPharma, Inc. | 1.02 Million USD | 6465.656% |
| NovAccess Global Inc. | -4.76 Million USD | -1266.124% |
| Affymax, Inc. | -14.42 Million USD | -351.699% |
| Itoco Inc. | -1.86 Million USD | -3385.991% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -1366.573% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -3803.715% |
| Mobile Lads Corp. | -2.26 Million USD | -2778.683% |
| CytoDyn Inc. | -49.84 Million USD | -30.722% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -82337.716% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -28459.969% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -6819.914% |
| SYBLEU INC | -180.3 Thousand USD | -36035.083% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -3939.902% |
| International Stem Cell Corporation | -131 Thousand USD | -49635.115% |
| Bioxytran, Inc. | -4.28 Million USD | -1422.266% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -119949.012% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -2474.966% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | -35.532% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -2981.977% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -8243.461% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -1956.597% |
| Neutra Corp. | -233.46 Thousand USD | -27806.967% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -221.093% |
| PureTech Health plc | -65.69 Million USD | 0.828% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -206.364% |
| IXICO plc | -1.17 Million USD | -5430.815% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -556.321% |
| Gelesis Holdings, Inc. | -57.12 Million USD | -14.047% |
| CSL Limited | 2.64 Billion USD | 102.466% |
| Cellectis S.A. | -103.17 Million USD | 36.851% |